Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1

BACKGROUND: Clinical resistance to chemotherapeutic agents is one of the major hindrances in the treatment of human cancers. Erythroblastosis virus E26 oncogene homolog 1 (ETS1) is involved in the drug resistance of various cancer cells, and is overexpressed in drug-resistant human breast cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jinrong, Zhou, Yong, Jiang, Guo-Qin, Xiao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995875/
https://www.ncbi.nlm.nih.gov/pubmed/24602286
http://dx.doi.org/10.1186/1475-2867-14-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995875/
https://www.ncbi.nlm.nih.gov/pubmed/24602286
http://dx.doi.org/10.1186/1475-2867-14-22

Ejemplares similares